Letters, calls and emails: Concern over statin switching

Dear Editor

I am concerned with the current drive for switching for several reasons and am writing on a basis of being a predominant simvastatin prescriber.  

This afternoon I saw a man on 10mg of atorvastatin, a cholesterol of 3.8 and an MI 20 years ago at the age of 40, currently ‘well’. If I was him I would not want to be switched. That is the argument at a personal level.  

The NHS agrees a tariff price, I believe, with manufacturers — why, if atorvastatin is too dear is this not sorted centrally?  

However, I am also surprised that the manufacturer does not cut its losses and reduce the price.  

Finally, this needs to be considered with the agenda of research costs. I live and work near a huge pharma research base. This needs funding; if we change everything to the cheapest generic eventually the Western research market will move away which might have even greater risks to the NHS. Bigger NHS savings could be made by abandoning the private finance initiative and amending the current computer programme.  

Dr John Sharvill  

Deal, Kent 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus